Skip to content

Comparison of Results of Platelet Rich Plasma (PRP) Versus Steroid injection for heel pain

To Comparison of Efficacy of Local Injection of Platelet Rich Plasma With Corticosteroid in the Treatment of Plantar Fasciitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027298
Enrollment
100
Registered
2020-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

Intervention1: PRP injection: A bench-top centrifuge was used to concentrate platelets from autologous whole blood. 2 ml of PRP was obtained using a single step centrifugation procedure. 10ml of blood

Sponsors

Dr BSA Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study will be conducted on adults having heel pain for more than 4 weeks who were clinically diagnosed as plantar fasciitis and attending the outpatient department of our hospital. After taking due consent, participants were randomized using envelope method into 2 groups: Group A was given local injection of Corticosteroid and Group B was given local injection of Platelet Rich Plasma. All of the patients underwent conventional radiographs and magnetic resonance imaging (MRI) of the involved foot to rule out stress fractures, associated bone lesions or other causes of plantar heel pain. The inclusion criteria consists of skeletally mature patients with heel pain at plantar fascia insertion, failure of conservative treatment for 4 weeks and no previous injections.

Exclusion criteria

Exclusion criteria: patients needing bilateral injections, patients with associated pathologies, inflammatory or degenerative osteoarthritis, uncontrolled diabetes, neurological conditions, skin infections, or a history of infection at the application site in the previous 3 months.

Design outcomes

Primary

MeasureTime frame
VAS scoreTimepoint: 6 months

Secondary

MeasureTime frame
AOFAS scoreTimepoint: 6 Months;ComplicationsTimepoint: 0

Countries

India

Contacts

Public ContactDr Vaneet Dhankar

Dr BSA Medical college and Hospital

ankit24388@gmail.com8437029392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026